The goal of our study was to examine tumor infiltrating Foxp3+CD4+, CD4+ and CD8+ T cells by immunohistochemistry in specimens of NSCLC patients and evaluate the prognostic value of these cells especially of Foxp3+CD4+ . The gene discussed is FOXP3; the disease is non-small cell lung carcinoma.